ArticleMedicine international
Crohn's disease and ulcerative colitis in β-thalassemia major: A report of two cases and a brief review of the literature.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The co-occurrence of β-thalassemia major and inflammatory bowel disease is exceedingly rare, yet clinically important, as overlapping manifestations such as severe anemia, fatigue, abdominal pain and dysentery may mask the underlying inflammatory bowel disease and delay diagnosis. The patients described in the present case report exhibited markedly elevated levels of inflammatory markers and fecal calprotectin levels (>1,000 µg/g); these findings, together with colonoscopic and histopathological findings, enabled the diagnosis of both major inflammatory bowel disease subtypes, namely Crohn's disease and ulcerative colitis. These cases add to the limited literature available by demonstrating that inflammatory bowel disease should be considered in patients with β-thalassemia major presenting with persistent gastrointestinal symptoms, particularly when symptoms are disproportionate to baseline disease manifestations. Early clinical suspicion, prompt diagnostic evaluation, and multidisciplinary management are crucial for preventing further clinical deterioration, minimizing complications and improving long-term outcomes. However, further studies are warranted to clarify the potential pathophysiological association and establish optimal management strategies for this rare coexistence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.